Mirum Pharmaceuticals, Inc. (MIRM)

91.74 +0.69 (+0.76%) USD  |  NASDAQ  |  Jan 20, 14:19
More

Mirum Pharmaceuticals Long Term Deferred Assets (Quarterly)

Long Term Deferred Assets (Quarterly) Chart

View Long Term Deferred Assets (Quarterly) for MIRM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Assets (Quarterly) Benchmarks

View Long Term Deferred Assets (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
XOMA Royalty Corp. --
Arcutis Biotherapeutics, Inc. --
Recursion Pharmaceuticals, Inc. Upgrade
Insmed, Inc. --